Empresa BioLineRx Ltd. TEL AVIV STOCK EXCHANGE
Acciones
BLRX
IL0011015182
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
ILS en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
License
96,0
%
| - | - | 17 | 96,0 % | - |
Oncology and Hematology
4,0
%
| 0 | nan % | 1 | 4,0 % | - |
Ventas por región
ILS en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 0 | nan % | 18 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Philip Serlin
CEO | Chief Executive Officer | 62 | 24/05/09 |
Mali Zeevi
DFI | Director of Finance/CFO | 48 | 01/01/09 |
Irit Gliko-Kabir
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/17 |
John Lacey
IRC | Investor Relations Contact | - | - |
Asaf Aloni
PRN | Corporate Officer/Principal | - | - |
Tali Yaron Dalah
AUD | Comptroller/Controller/Auditor | 46 | - |
Ella Sorani
PRN | Corporate Officer/Principal | 56 | 01/02/17 |
Holly May
PRN | Corporate Officer/Principal | - | 16/06/22 |
Corporate Officer/Principal | - | 01/08/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Sandra Panem
BRD | Director/Board Member | 77 | 24/02/14 |
Avraham Molcho
BRD | Director/Board Member | 66 | 01/01/10 |
Aharon Schwartz
CHM | Chairman | 80 | 01/01/04 |
Director/Board Member | 65 | 19/08/13 | |
Raf Hofstein
BRD | Director/Board Member | 74 | 01/01/03 |
Rami Dar
BRD | Director/Board Member | 67 | 01/07/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 199 089 165 | 1 194 817 450 ( 99,64 %) | 0 | 99,64 % |
Información de la empresa
BioLineRx Ltd.
Modi'in Technology Park 2 HaMa'ayan Street
7177871, Modi'in
+972 8 642 9100
http://www.biolinerx.comSector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,26 % | 103 mil M | |
+1,41 % | 95,71 mil M | |
-0,03 % | 22,02 mil M | |
-17,84 % | 20,9 mil M | |
-9,21 % | 17,85 mil M | |
-42,83 % | 16,21 mil M | |
-17,63 % | 15,52 mil M | |
+4,55 % | 13,86 mil M | |
+32,11 % | 12,04 mil M |